CareDx Operating Cycle from 2010 to 2026

CDNA Stock  USD 19.35  1.28  6.20%   
CareDx's Operating Cycle is increasing over the years with slightly volatile fluctuation. Operating Cycle is expected to dwindle to 83.14. From 2010 to 2026 CareDx Operating Cycle quarterly data regression line had arithmetic mean of  96.66 and r-squared of  0.62. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
122.02
Current Value
83.14
Quarterly Volatility
36.94592451
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check CareDx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CareDx's main balance sheet or income statement drivers, such as Depreciation And Amortization of 23.9 M, Interest Expense of 3.7 M or Selling General Administrative of 149.5 M, as well as many indicators such as Price To Sales Ratio of 4.13, Dividend Yield of 0.0 or PTB Ratio of 2.82. CareDx financial statements analysis is a perfect complement when working with CareDx Valuation or Volatility modules.
  
Build AI portfolio with CareDx Stock
Check out the analysis of CareDx Correlation against competitors.
Analyzing CareDx's Operating Cycle over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Operating Cycle has evolved provides context for assessing CareDx's current valuation and future prospects.

Latest CareDx's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of CareDx Inc over the last few years. It is CareDx's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CareDx's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

CareDx Operating Cycle Regression Statistics

Arithmetic Mean96.66
Geometric Mean88.79
Coefficient Of Variation38.22
Mean Deviation33.12
Median117.02
Standard Deviation36.95
Sample Variance1,365
Range94.5009
R-Value0.79
Mean Square Error555.16
R-Squared0.62
Significance0.0002
Slope5.75
Total Sum of Squares21,840

CareDx Operating Cycle History

2026 83.14
2025 122.02
2024 135.58
2023 136.16
2022 137.77
2021 138.0
2020 123.65

About CareDx Financial Statements

CareDx stakeholders use historical fundamental indicators, such as CareDx's Operating Cycle, to determine how well the company is positioned to perform in the future. Although CareDx investors may analyze each financial statement separately, they are all interrelated. For example, changes in CareDx's assets and liabilities are reflected in the revenues and expenses on CareDx's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CareDx Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Cycle 122.02  83.14 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether CareDx Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CareDx's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Caredx Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Caredx Inc Stock:
Check out the analysis of CareDx Correlation against competitors.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CareDx. Projected growth potential of CareDx fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive CareDx assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
1.28
Revenue Per Share
6.619
Quarterly Revenue Growth
0.207
Return On Assets
(0.04)
Return On Equity
0.2411
Understanding CareDx Inc requires distinguishing between market price and book value, where the latter reflects CareDx's accounting equity. The concept of intrinsic value - what CareDx's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push CareDx's price substantially above or below its fundamental value.
It's important to distinguish between CareDx's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CareDx should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, CareDx's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.